1.Alexithymia in patients with bronchial asthma.
Sang Mi OH ; Heung Bum LEE ; Yong Chul LEE ; Yang Keun RHEE ; Ae Ja JUNG
Journal of Asthma, Allergy and Clinical Immunology 1998;18(3):434-440
BACKGROUND: Alexithymia refers to a specific disturbance in psychic functioning characterized by difficulties in capacity to verbalize affect and to elaborate fantasies. Although initially described in the context of psychosomatic illness, alexithymic characteristics may be observed in patients with a wide range of medical and psychiatric disorders. OBJECTIVE: The present study was to evaluate the relationship between the alexithymia and bronchial asthma, and to compare the results with finding from a group of acute infectious illness subjects. MATERIAL AND METHOD: Alexithymia was measured with on Korean translation of the TAS-20 (Toronto Alexithymic Scale-20 Korea version) and the Scored Archetypal 9 Test(SAT9). Thirty patients with bronchial asthma and thirty patients with acute infectious illness completed these tests. The SAT9 and the TAS-20K scores were compared in the both group, considering the age, gender, education level, and duration of illness. RESULT: Bronchial asthma patients had significantly higher score of on the TAS-20K and SAT9 compared with those with infectious illness(p<0.05). The two scales correlated in expected direction. Alexithymia was significantly related to education level(SAT9: r=0.335, TAS-20K: r=-0.376, p<0.01) and duration of illness(asthma group, SAT9: r=-0.383, TAS-20K: r=0.288, p<0.05). CONCLUSION: Bronchial asthma patients had significantly higher alexithymic scores. This finding suggests that psycliathic consultation may be considered for the management of asthmatic patients with alexithyria.
Affective Symptoms*
;
Asthma*
;
Education
;
Fantasy
;
Humans
;
Korea
;
Weights and Measures
2.Two cases of intrabronchial neurilemmoma.
Chul Min AHN ; Heung Bum LEE ; Yong Chul LEE ; Yang Keung RHEE
Tuberculosis and Respiratory Diseases 2000;49(2):225-230
Neurilemmoma is rare benign tumor originating from the Schwann cell of the nerve sheath. Intrabronchial neurilemmoma are extremely rare and only few cases have been reported previously in Korea. Neurilemmoma at all ages but are most common in persons between the ages of 20 and 50 years. It affects the head, neck, flexor regions of the extremities. Neurilemmoma was confirmed histologically because of the presence of Verocay bodies, Antoni A or B tissue pattern and of S-100 protein. We report two cases of intrabronchial neurilemmoma with chronic coughing and nonspecific radiologic findings.
Cough
;
Extremities
;
Head
;
Humans
;
Korea
;
Neck
;
Neurilemmoma*
;
S100 Proteins
3.Comparisons of 12-Hour and 24-Hour Sustained-Release Theophyllines in the Management of Asthma.
Yang Deok LEE ; Seoung Ju PARK ; Heung Bum LEE ; Yong Chul LEE ; Yang Keun RHEE
Tuberculosis and Respiratory Diseases 2001;50(3):293-299
BACKGROUND: Sustained-release theophylline, which is generally prescribed as a twice-daily equal-dose regimen, is one of the more common asthma treatments. the development of a sustained-release drug delivery technology that enables improved control of the theophylline blood levels represents a significant advancement in both the efficacy and safety of dosing. METHOD: A crossover study was conducted with 25 adult chronic asthmatic patients requiring daily bronchodilator therapy. The study group included thirteen males and twelve females with ages ranging from 19 to 71 years. The overall approach was to place the patients first on the twice-daily preparation(Etheophyl®) for 28 days at 8 AM and 8 PM, and measure the pulmonary function and theophylline level on the 28th day. the patients were subsequently switched to the once-daily preparation(Uniphyl®) in the same daily dose at 8 PM on the 29th day and the same parameters were measured on the 56th day. RESULTS: the mean serum levels of theophylline were 8.18±1.66µg/ml in the Etheophyl®-treated period and 8.00±1.75µg/ml in the Uniphyl®-treated period. In addition, the FEV1 showed 71.40±7.48 percent in the Etheophyl®-treated and 69.18±9.00 percent in the Uniphyl®-treated period. Thus there were no significant differences between the once-daily and twice-daily preparation. CONCLUSION: The results indicated little clinical differences between the two medication. The two drugs are equally effective in controlling asthma over the four weeks of treatment.
Adult
;
Asthma*
;
Cross-Over Studies
;
Female
;
Humans
;
Male
;
Theophylline
4.Changes of sICAM-1, sVCAM-1 and sE-selectin levels in Sera of the Patients with Lung Cancer.
Sang In CHOI ; Heung Bum LEE ; Yong Chul LEE ; Yang Keun RHEE
Korean Journal of Medicine 1998;54(6):737-744
No abstract available.
Humans
;
Lung Neoplasms*
;
Lung*
5.A Clinical Study on the Traumatic Hyphema.
Heung Yong RHEE ; Kyung Sook HAN
Journal of the Korean Ophthalmological Society 1980;21(4):505-509
Authors have experienced 30 cases of traumatic hyphema for the recent 3 years. We treated all the patients by absolute bed rest. binocular patches, enzyme and osmotherapy, and in some cases, anterior chamber irrigation was performed. The following conclusions were obtained; 1) It took 2~3 1/2 days to be absorbed in the cases of hyphema less than one-quarter volume of anterior chamber. 2) It took 4-16 days in the cases of total hyphema. 3) In most cases of hyphema more than three-quarters volume of anterior chamber, they were associated with other ocular injuries and also shawed poar visual prognosis.
Anterior Chamber
;
Bed Rest
;
Humans
;
Hyphema*
;
Prognosis
;
Telescopes
6.Pulmonary mucormycosis with an appearance of consolidation.
Shin Chae KIM ; Heung Bum LEE ; Yong Chul LEE ; Yang Keun RHEE
Tuberculosis and Respiratory Diseases 2000;49(1):117-121
The mucormycosis is a group of serious opportunistic infections caused by fungi of the class Zygomycetes and order Mucorales. Pulmonary mucormycosis is a relatively rare disease but typically manifested by a rapidly progressive, often fatal pneumonia in patients with diabetes mellitus, hematologic malignant neoplasms, or organ transplants. The radiologic manifestations of pulmonary mucormycosis are nonspecific and include progressive lobar or multilobar consolidations, pulmonary masses and pulmonary nodules. Recently, we experienced a pulmonary mucormycosis in 32-year-old man with uncontrolled diabetes. He complained of cough, left pleuritic chest pain and generalized weakness. Initial chest X-ray finding was the consolidation on the lower lobe of the left lung. On the sixth hospital day, bronchoscopic examination with lung biopsy revealed broad, non-septate hyphae with right-angle branching, diagnostic of mucormycosis, and consequently amphotericin B therapy was started. We performed a lobectomy of the left lower lobe of the lung on 29th hospital day.
Adult
;
Amphotericin B
;
Biopsy
;
Chest Pain
;
Cough
;
Diabetes Mellitus
;
Fungi
;
Humans
;
Hyphae
;
Lung
;
Mucorales
;
Mucormycosis*
;
Opportunistic Infections
;
Pneumonia
;
Rare Diseases
;
Thorax
;
Transplants
7.A Case of Bronchogenic Squamous Cell Carcinoma in Patient with Swyer-James Syndrome.
Seoung Ju PARK ; Heung Yong JIN ; Bo Geum CHOI ; Koang Ho CHOI ; Heung Bum LEE ; Yong Chul LEE ; Yang Keun RHEE
Tuberculosis and Respiratory Diseases 2001;50(2):252-257
No abstract available.
Carcinoma, Squamous Cell*
;
Humans
;
Lung, Hyperlucent*
8.Vascular Endothelial Growth Factor and Matrix Metalloproteinase-9 in Acute Asthma.
Kang Seo PARK ; Hung Yong JIN ; Eugene CHOI ; Heung Bum LEE ; Yang Keun RHEE ; Yong Chul LEE
Tuberculosis and Respiratory Diseases 2001;51(6):530-539
BACKGROUND: Bronchial asthma is an inflammatory disease of the airways that is associated with airway remodeling. The vascular endothelial growth factor (VEGF) is a potent, multifunctional cytokine that contributes to angiogenesis and inflammation. Matrix metalloproteinase-9 (MMP-9) is a major proteolytic enzyme that induces bronchial remodeling in asthma. However, there is no data available on the possible role of the VEGF or on the potential relationship between the VEGF and MMP-9 in acute asthma. Therefore, the VEGF was studied to determine whether or not it participates in airway inflammation during acute asthma. An additional aim of this study was to determine whether or not the VEGF levels correlated with the MMP-9 levels in the sputum of acute asthma patients. METHODS: Both the VEGF and MMP-9 levels were measured by an enzyme immunoassay and zymographic analysis in the sputum of patients with either stable asthma or with acute asthma. The VEGF and MMP-9 levels were also evaluated during a spontaneous asthma attack. RESULTS: The VEGF levels were significantly higher in the sputum of acute asthmatic patients than in either the stable patients the control subjects. The VEGF levels in the sputum during asthma exacerbation were significantly higher than those on the remission days, and those levels decreased after decreased after asthma therapy. In acute asthmatic patients, the VEGF levels in the sputum correlated with the number of neutrophils and eosinophils. In addition, a significant correlation was established between the VEGF and MMP-9 levels in the sputum. CONCLUSION: These results suggest that VEGF overproduction is associated with airway inflammation during acute asthma and is related to the MMP-9 function.
Airway Remodeling
;
Asthma*
;
Eosinophils
;
Extracellular Matrix
;
Humans
;
Immunoenzyme Techniques
;
Inflammation
;
Matrix Metalloproteinase 9*
;
Neutrophils
;
Sputum
;
Vascular Endothelial Growth Factor A*
9.Renal localization of Ga-67 citrate in noninfectious nephritis.
Kang Wook LEE ; Min Soo JEONG ; Sunn Kgoo RHEE ; Sam yong KIM ; Young Tai SHIN ; Heung Kyu RO
Korean Journal of Nuclear Medicine 1992;26(2):318-326
No abstract available.
Citric Acid*
;
Nephritis*
10.Effects of Erythromycin and New Macrolides on the Serum Theophylline Level and Clearance.
Heung Bum LEE ; Yong Chul LEE ; Yang Keun RHEE
Tuberculosis and Respiratory Diseases 1998;45(3):546-552
BACKGROUND: Up to 90% of a theophylline dose is biotransformed, by interaction with one or more the variants of the cytochrome P-450 drug metabolism system. Macrolides affect the elimination of theophylline by influencing on the microsomal enzyme systems. We evaluate the effect of erythromycin and new macrolides on the serum theophylline level and clearance. METHOD: Subjects consisted of moderate asthmatic patients with normal renal and hepatic functions. All subjects were non-smokers and treated with oral theophylline 400mg per day. We randomly assigned 53 patients into four groups. Each group was treated with one macrolides, the first group erythromycin(n: 19, 500 mg bid), second roxitbromycin (n: 14. 150 mg bid), third clarithromycin (n: 10, 250 mg bid) and fourth azithromycin(n: 10, 250 mg bid). We measured the serum theophylline level and clearance at three intervals, at pretreatment, after the first and fourth week after receiving the following macrolides, erythromycin, roxithromycin and clarithromycin. When azithromycin was administered, the serum theophylline level was measured at pretreatment and after one week of treatment They were measured by a computerized program of Bayesian method. RESULTS: When compared with control, erytbromycin and roxithromycin-treated groups had a significantly elevated serum theophylline level and decreased clearance. However, there were no significant changes of the serum theophylline level and clearance in clarithromycin and azithromycin-treated groups. CONCLUSION: These results suggest that theophylline dose may need to be readjusted and have periodic drug monitoring when erythromycin or roxithromycin is administered concurrenfly.
Azithromycin
;
Bayes Theorem
;
Clarithromycin
;
Cytochrome P-450 Enzyme System
;
Drug Monitoring
;
Erythromycin*
;
Humans
;
Macrolides*
;
Metabolism
;
Roxithromycin
;
Theophylline*